TrumpRx Prices Are Attracting Attention from Other Supply Chain Heavyweights

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  

So there won’t be news this week on the government’s opening offer** around price controls for the first 10 medicines selected under the Inflation Reduction Act. Companies will get the

Programming Note: Cost Curve is off tomorrow. Back Monday. Of course, that’s what I said last week, too, and look where that got me. There is a new analysis from